NCT02370069View on ClinicalTrials.gov

The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13

PHASE4CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Chronic Kidney Diseases
Interventions
BIOLOGICAL

Prevnar 13

One dose of 0.5 mL Prevnar 13 injected intramuscularly into the deltoid muscle on Day 0.

Trial Locations (1)

P7B 6V4

Thunder Bay Regional Health Sciences Centre, Thunder Bay

All Listed Sponsors
lead

Lakehead University

OTHER

NCT02370069 - The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13 | Biotech Hunter | Biotech Hunter